Le Lézard
Classified in: Health
Subjects: NPT, EXE, POL, AVO

Emergency Physicians Call on Biden Administration to Amend Interim Final Rule on Surprise Billing


WASHINGTON, Nov. 9, 2021 /PRNewswire/ -- The American College of Emergency Physicians (ACEP) stands firmly with the over 150 bipartisan members of Congress who call urgently on the Biden Administration to change the interim final rule (IFR) that details how to implement the No Surprises Act.

ACEP and other leaders throughout the medical community are deeply concerned that the IFR as written is a drastic departure from the legislation passed by Congress last December to resolve billing disputes fairly and without bias through an independent dispute resolution process.

Congress is also raising the alarm. On November 5, 2021 Reps. Tom Suozzi (D-NY), Brad Wenstrup, DPM (R-OH), Raul Ruiz, MD (D-CA), and Larry Bucshon, MD (R-IN) sent a letter to Health and Human Services Secretary Xavier Becerra, Labor Secretary Martin Walsh, and Treasury Secretary Janet Yellen expressing concern with how the administration plans to implement the No Surprises Act. The letter has broad support with 152 bipartisan members of Congress signing on?nearly a third of the chamber. It states:

"Unfortunately, the parameters of the [independent dispute resolution] process in the IFR released on September 30 do not reflect the way the law was written, do not reflect a policy that could have passed Congress, and do not create a balanced process to settle payment disputes." 

The No Surprises Act includes a dispute resolution process forged through bipartisan compromise to ensure a fair interaction between insurance companies and physicians. In the final legislation, Congress intentionally rejected options that would give single pieces of information outsized influence in billing disputes. But, the IFR would have arbiters give unequal weight to the qualified payment amount (the insurer's artificially low median in-network rate for reimbursement), rather than a balanced mix of other factors in the process.

Emergency physicians are deeply concerned that this giveaway to insurance companies will undermine the entire effort to solve surprise billing. This approach would drive reimbursement rates lower and encouraging insurance companies to narrow their networks even further, which would make it harder for patients to get emergency care.

"This rule turns a blind eye to a carefully crafted bipartisan compromise that took years to reach," said Gillian Schmitz, MD, FACEP, president of ACEP. "Unless it is changed, the IFR hands insurance companies an enormous amount of leverage in billing disputes and will make it much harder for emergency physicians to care for patients, especially in small or rural communities."

ACEP will continue to raise concerns about this flawed rule with legislators and regulators to ensure that this legislation can accomplish what it was thoughtfully designed to do?protect patients from surprise bills without threatening access to emergency care.

The American College of Emergency Physicians (ACEP) is the national medical society representing emergency medicine. Through continuing education, research, public education, and advocacy, ACEP advances emergency care on behalf of its 40,000 emergency physician members, and the more than 150 million Americans they treat on an annual basis. For more information, visit www.acep.org and www.emergencyphysicians.org

SOURCE American College of Emergency Physicians (ACEP)


These press releases may also interest you

at 09:25
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, provides an update on the initiative to...

at 09:23
To mark mental health awareness, OOt Social Health proudly launches its app to revolutionise community engagement. OOt Social Health represents a paradigm shift in fostering vibrant communities through face-to-face interactions, blending proximity,...

at 09:21
Scinai Immunotherapeutics Ltd. , a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bioservices business unit, today announced that it had had...

at 09:20
NanoTemper Technologies, well known for creating biophysical tools that accelerate the work of drug discovery researchers, brings their groundbreaking Spectral Shift technology to the protein production market with the release of Andromeda X, an...

at 09:15
In the sea of content today, customers ? HCPs and consumers alike ? are overwhelmed with information. This content might be reaching them, but not effectively resonating and activating them to change behaviors. Cutting through this noise requires...

at 09:15
NextPoint Therapeutics, a clinical-stage biotechnology company developing a new class of precision immuno-oncology and tumor-directed therapeutics targeting the novel B7-H7/HHLA2 axis, announced today that Chief Executive Officer Ivan Cheung has been...



News published on and distributed by: